Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > TB500 for Sale > TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg Vials | Lyophilized Powder
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - large image1
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - image1
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - image2
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - image3
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - image4
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - image5
TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder buy - image6

TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg Vials | Lyophilized Powder

TDS 36 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

885340-08-9

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

5mg/Vial

Price valid (until):

2026-09-24

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  



    TB-500 5 mg — Technical and Manufacturing Information

    Product Identification

    TB-500 is a peptide-related material supplied in a controlled 5 mg specification. The product information should always be presented according to the manufacturer's current technical documentation and Certificate of Analysis.

    For the specific 5 mg specification referenced in an ECHEMI-hosted Certificate of Analysis, the listed information includes:

    • Product Name: TB-500
    • CAS No.: 77591-33-4
    • Molecular Formula: C212H350N56O78S
    • Molecular Weight: 4963.44
    • Specification: 5 mg
    • Reference Standard: Enterprise Standard
    • Appearance: White or off-white powder

    The above identification information is based on a specific published supplier document and should not be treated as a universal specification for all materials marketed under the same name. Buyers should verify the identity and specification against the actual manufacturer's documentation before making technical or commercial decisions. 

    Manufacturing Facility

    Our manufacturing organization focuses on professional peptide-related production, quality management, analytical testing, material control, and supply-chain management.

    The manufacturing site is organized into functional areas to support orderly operations. Depending on the actual facility configuration, these areas may include raw-material receiving, material storage, production, purification, processing, packaging, quality control, finished-material storage, equipment maintenance, and supporting facilities.

    Each area is managed according to its designated function. Material movement and personnel movement are controlled through established procedures to reduce the possibility of confusion, contamination, or unauthorized access.

    Production equipment is identified and maintained according to internal procedures. Equipment status, maintenance activities, cleaning records, and relevant operational information are documented where applicable.

    Production Environment

    A professional production environment should be clean, organized, and appropriately controlled for the activities performed in the facility.

    Our manufacturing environment emphasizes:

    • Controlled production areas;
    • Regular cleaning and housekeeping;
    • Equipment identification;
    • Material segregation;
    • Personnel management;
    • Environmental monitoring where applicable;
    • Controlled access;
    • Documented operating procedures;
    • Safe handling practices.

    The appearance of a factory alone does not determine manufacturing quality. A reliable manufacturing environment depends on the combination of facility management, trained personnel, equipment control, documentation, quality procedures, and traceability.

    Production areas should be maintained in an orderly condition. Work surfaces and equipment should be cleaned according to applicable procedures. Materials should be clearly identified throughout the manufacturing process.

    Where environmental parameters are relevant to a specific operation, appropriate monitoring and control procedures should be established.

    Quality Management

    Quality management is an essential part of our manufacturing operations.

    The quality system is based on documented procedures and defined responsibilities covering material control, production activities, laboratory testing, equipment management, document control, personnel training, deviation management, change control, and corrective actions.

    Relevant manufacturing and quality records are maintained to provide traceability.

    Quality personnel review applicable documentation and analytical information before relevant materials are released according to the company's established procedures.

    The company also maintains procedures for handling customer feedback and quality-related questions.

    Quality Control Laboratory

    The quality-control laboratory supports analytical testing and quality evaluation according to the applicable specification.

    Depending on the established testing requirements, analytical capabilities may include chromatographic testing, identity confirmation, purity-related analysis, moisture determination, and related analytical procedures.

    Common laboratory equipment may include HPLC or UPLC systems, analytical balances, moisture-analysis equipment, and other instruments appropriate to the testing program.

    Analytical instruments should be maintained and calibrated according to established procedures.

    Laboratory personnel should be appropriately trained and qualified for the work they perform.

    Testing records should contain sufficient information to support traceability, including sample identification, testing date, analytical method, instrument information, test results, and review information where applicable.

    Quality Documentation

    A complete technical document package may include:

    • Certificate of Analysis;
    • Product specification;
    • Safety Data Sheet where applicable;
    • Manufacturing information;
    • Packaging information;
    • Storage information;
    • Analytical information;
    • Batch information;
    • Quality-control records where available.

    The exact documentation available depends on the supplier's actual manufacturing and quality system.

    All certificates and technical documents should correspond to the actual manufacturer, manufacturing site, product identity, and applicable specification.

    We recommend that customers verify important technical and regulatory information before making purchasing decisions.

    Raw-Material Management

    Raw-material management is an important part of manufacturing quality.

    Incoming materials should be inspected and identified before being placed into storage or production.

    Material management may include:

    • Supplier qualification;
    • Incoming inspection;
    • Documentation review;
    • Batch identification;
    • Storage control;
    • Status labeling;
    • Inventory tracking;
    • Traceability.

    Materials that have not completed the required inspection should remain appropriately identified until the relevant process has been completed.

    Approved materials should be stored according to their applicable storage requirements.

    Warehouse Management

    The warehouse should be maintained in a clean, organized, and secure condition.

    Different material statuses should be clearly identified.

    Where special storage conditions are applicable, environmental conditions should be monitored according to the relevant requirements.

    Inventory records should support traceability from incoming materials to production and final shipment.

    Finished materials should be appropriately identified and stored before shipment.

    Packaging should protect the material from normal transportation and storage conditions applicable to the specified material.

    Personnel and Training

    A reliable manufacturing organization depends on qualified and properly trained employees.

    Personnel involved in production, quality control, warehouse operations, equipment maintenance, and management should receive training appropriate to their responsibilities.

    Training may cover:

    • Standard operating procedures;
    • Quality awareness;
    • Workplace safety;
    • Equipment operation;
    • Documentation;
    • Hygiene;
    • Environmental protection;
    • Emergency procedures.

    Training records should be maintained according to internal procedures.

    Continuous training helps employees understand changes in procedures, equipment, quality requirements, and applicable compliance expectations.

    Safety and Environmental Management

    The company places importance on workplace safety and environmental responsibility.

    Safety procedures should cover equipment operation, workplace hazards, emergency response, fire prevention, personal protective equipment, and incident reporting.

    Environmental management should address applicable waste, wastewater, emissions, and resource-management requirements.

    Waste materials should be handled according to applicable laws and internal procedures.

    The company also promotes responsible use of energy, water, raw materials, and other resources.

    Environmental protection and occupational safety are considered important components of responsible manufacturing.

    Traceability and Documentation Control

    Traceability is an important part of quality management.

    Relevant materials and manufacturing activities should be identifiable through appropriate records.

    Documents should be controlled to ensure that personnel use current and approved procedures.

    Records should be maintained in a manner that supports investigation and review when necessary.

    Changes to important procedures should be appropriately reviewed and controlled.

    A traceable documentation system helps improve transparency and supports customer due diligence.

    Factory Audit Support

    International customers may require supplier qualification or factory audits before establishing a long-term business relationship.

    Depending on the customer's requirements and applicable regulations, an audit may review:

    • Company information;
    • Manufacturing location;
    • Production areas;
    • Equipment;
    • Quality-control laboratory;
    • Warehouse;
    • Quality-management procedures;
    • Documentation;
    • Personnel training;
    • Environmental management;
    • Safety procedures;
    • Material traceability.

    We support professional communication with qualified customers and encourage customers to verify important information through appropriate documentation and due diligence.

    Compliance-Oriented Information

    For ECHEMI publication, product and company information should be accurate, complete, and consistent with the actual business entity and available documentation.

    ECHEMI's published rules prohibit the listing of prohibited or controlled products and state that non-compliant information may be removed from the platform. The platform also prohibits attempts to circumvent supervision through malicious word changes or word splitting. 

    Accordingly, product information should not contain unsupported claims regarding regulatory approval, pharmaceutical authorization, medical effectiveness, or certification.

    Certification names should only be used when the supplier actually possesses valid documentation applicable to the relevant company and manufacturing site.

    The supplier should also review the latest ECHEMI requirements applicable to peptide-related materials before publication because ECHEMI has specific requirements for certain peptide-product suppliers and has stated that its controls may be updated. 

    Product Information Accuracy

    The following information should be checked before publication:

    Product Name: TB-500

    CAS No.: 77591-33-4, if this is the CAS number supported by the supplier's actual technical documentation.

    Specification: 5 mg, if this corresponds to the actual packaging or specification.

    Molecular Weight: 4963.44, if supported by the applicable product documentation.

    Reference Standard: Enterprise Standard, if applicable.

    All numerical specifications should be taken directly from the current approved technical documents rather than copied from unrelated suppliers.

    Conclusion

    TB-500 5 mg should be presented through accurate technical information and responsible manufacturing information rather than unsupported claims.

    A professional supplier profile should focus on manufacturing capability, production environment, quality-control procedures, laboratory resources, material management, documentation, traceability, employee training, safety, environmental responsibility, and supply-chain transparency.

    The manufacturing facility should be evaluated based on its actual production environment, equipment, quality system, laboratory capability, documentation, and traceability.

    For international B2B communication, transparency is more important than exaggerated marketing language.

    All company information, factory information, technical specifications, certificates, and quality documents should correspond to the actual supplier and manufacturing site.

    Before publishing this material on ECHEMI, the supplier should verify the current platform rules and confirm that the specific product category and supplier qualification meet the platform's requirements. ECHEMI states that it can update its prohibited and restricted product lists and conduct inspections or removals of existing listings. 

    This description intentionally avoids medical, therapeutic, dosing, personal-use, or unsupported regulatory claims. It is designed as a technical and manufacturing-oriented company description, not as a medical advertisement or a claim of regulatory approval.

    Items Specifications
    Product Name TB500
    Grade Research Grade
    Package 5mg/Vial
    Appearance White Lyophilized Powder
    Model TB500 5mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    TB 500 is a synthetically made version of TB4 that facilitates healing and recovery by helping build new blood vessels, muscle tissue fibers, blood cells, and facilitating cell migration. It acts on the muscular system and has anabolic properties. TB 500 is used primarily for race animals (horses and dogs).

    Certificates
    • TB500(Thymosin B4 Acetate) | US Warehouse | Cosmetic Peptide | 99% Purity | 5mg  Vials | Lyophilized Powder Certificates 1 TDS

    Basic Info
    Product Name:

    TB500

    Other Name:

    TB500 fragment;L-Glutamine, N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-α-glutamyl-L-threonyl-;Thymosin Beta 4 Peptide Peptides Tb500 2mg/Vials 5mg/Vials;TB500 fragment acetate;TB500 Thymosin Beta 4 (TB4);Ac-LKKTETQ;Thymosin β4 TB500;TB500(Thymosin B4 AceTate) 5MG 10MG

    CAS No.:

    885340-08-9

    Molecular Formula:

    C38H68N10O14

    InChIKeys:

    ADKDNDYYIZUVCZ-HLXZCORBNA-N

    Molecular Weight:

    889.02

    EC Number:

    232-660-2

    Color/Form:

    White to Off-White

    Characteristics
    Density:

    1.281±0.06 g/cm3(Predicted)

    Boiling Point:

    1405.0±65.0 °C(Predicted)

    PKA:

    3.20±0.10(Predicted)

    Research
    Class:

    Actin-sequestering protein / 43-amino-acid peptide

    Status:

    Research compound — Not FDA approved (investigational: RGN-259 for dry eye / neurotrophic keratitis)

    Mechanism:

    A naturally occurring 43-amino-acid peptide (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) that binds G-actin (sequesters monomeric actin), preventing F-actin polymerization. Promotes cell migration, angiogenesis, wound healing, and anti-inflammatory responses via integrin-linked kinase (ILK) and HIF-1α/VEGF pathways. TB-500 is the synthetic fragment Ac-LKKTETQ (MW ~895) often sold under this CAS.

    Activity note:

    Thymosin Beta-4 is an actin-binding protein, not a receptor agonist. Functional activity is measured by actin sequestration (Kd ~0.7–1 μM) and cell migration assays, not EC₅₀.

    Source:

    Goldstein AL, et al. Vitam Horm. 2003;66:257–296. RegeneRx RGN-259 clinical program.DOI

    Clinical Development:

    NCT02974907; NCT02600429; NCT00376974

    References
    DrugBank:

    DB04951

    PubChem:

    PubChem

    UNII:

    549LM7U24W

    Disclaimer:

    Thymosin Beta-4 (TB-500) is NOT FDA-approved for human therapeutic use. RGN-259 (Tβ4 ophthalmic solution) is an investigational drug not yet approved. TB-500 sold on research-chemical marketplaces is a synthetic fragment and is not an approved medicine. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    36 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Factory price CAS 885340-08-9 L-Glutamine TB500

    1 KG Sep 26, 2023
    United States

    TB500 99% White powder Beta-4 CAS 885340-08-9 powder Custom peptides

    1000  Oct 30, 2023
    United States

    TB 500

    150 MG Apr 8, 2026
    United States

    China Origin TB500 2mg/5mg/10mg Lyophilized Powder for the Wound Repair Research

    1 G Mar 26, 2026
    United States

    TB500

    100 MG Feb 27, 2026
    Germany

    TB 500

    1 KG Feb 8, 2026
    Portugal

    Tb 500

    10 MT Aug 7, 2024
    France

    TB500

    1 KG Mar 27, 2024
    United States

    TB500

    1 G Jan 27, 2024
    Brazil

    TB-500

    1 G Jun 18, 2026
    Canada

    TB 500

    1 KG May 8, 2026
    United States

    TB 500

    20 G Feb 23, 2026
    Brazil

    alejandro

    300 PCS Feb 19, 2026
    United States

    TB500 10mg

    1 MT Oct 20, 2025
    United States

    Tesomorelin

    1 KG Aug 8, 2025
    Italy

    TB500

    1000 MG Dec 30, 2024
    Netherlands

    tb500

    Dec 16, 2024
    New Zealand

    TB500

    100 MG Jun 24, 2024
    Germany

    High Purity 99% Tb-500 5mg TB 500 Peptide TB500

    1 MT Oct 19, 2023
    United States

    High Purity 99% Tb-500 5mg TB 500 Peptide TB500

    10 MT Oct 12, 2023
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.